The AJMC® Heart Failure compendium is a comprehensive resource for clinical news and expert insights for the chronic condition in which the heart doesn't pump enough blood due to damaged heart muscle.
April 17th 2024
Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders.
Dr Amresh Raina: Cancer Treatments Are Affecting Heart Function in Many Ways
October 3rd 2022Amresh Raina, MD, director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania, is a board-certified advanced heart failure cardiologist, who is also certified in echocardiography and general cardiology.
Watch
Dr Amresh Raina on the Importance of Treating Dominant Disease Physiology in Comorbid HF
September 25th 2022When mapping out treatment strategy, it is important to first establish dominant disease physiology in patients who have heart failure (HF) and pulmonary hypertension, explained Allegheny Health Network's Amresh Raina, MD.
Watch
Contributor: Improving Utilization Management Can Better Outcomes, Cut Costs in Cardiovascular Care
September 18th 2022Russell Rotondo, MD, FACC, medical director of clinical strategy and innovation for cardiology at Cohere Health, discusses the myriad positive ways utilization management programs can have an impact on patient outcomes in cardiovascular care.
Read More
TAVR May Induce Early LVEF Improvement in Heart Failure
September 7th 2022This study investigated long-term mortality outcomes following transcatheter aortic valve replacement (TAVR) among patients with a left ventricular ejection fraction (LVEF) below 50% and comorbid severe aortic stenosis.
Read More
Methamphetamine Misuse Increases Risk of Adverse Heart Health Outcomes
August 29th 2022This new study investigated risk factors for cardiovascular disease, including heart failure, among hospitalized patients with a recent history of methamphetamine use and priority patient populations to target.
Read More
What We’re Reading: Premature Death Risk Factors; Pfizer Vaccine Efficacy; CVD Symptom Disparities
August 24th 2022People who experienced childhood poverty and other adversities are at greater risk of premature death in adulthood; Pfizer’s COVID-19 vaccine is 73% effective in protecting children younger than 5 years; women experience more symptoms of heart failure and other cardiovascular diseases than men.
Read More
Low-Dose Edoxaban Safe, Effective in Older Patients With AFib, High Bleeding Risk
August 23rd 2022This subanalysis of data from the ELDERCARE-AF trial investigated the safety and effectiveness of a 15-mg daily dose of the factor Xa inhibitor among older patients who have atrial fibrillation (AFib).
Read More
Heart Failure Prognosis Not Improved by Risk Score Prediction
August 10th 2022The REVEAL-HF study investigated using risk scores to improve patient outcomes through targeted interventions, including treatment initiation and intensity, end-of-life care, and hospitalization and mortality risks.
Read More
Gulati on Unequal CV Treatment for Women: “There Is a Bias in Our Care”
August 1st 2022Martha Gulati, MD, MS, kicked off the symposium “Saving the Hearts of Women Through Prevention” ahead of the 2022 Congress of the American Society for Preventive Cardiology, which took place Friday through Sunday in Louisville, Kentucky.
Read More
Gluckman Calls for Better Data, Payer Policies to Drive Value-Based CV Care
July 30th 2022Ty J. Gluckman, MD, FACC, FAHA, who is medical director of the Center for Cardiovascular Analytics, Research, and Data Science at Providence St. Joseph Health in Portland, Oregon, addressed the 2022 Congress of the American Society for Preventive Cardiology meeting in Louisville, Kentucky.
Read More
Air Pollution Exposure Linked With High Health Care Costs in Older People
July 24th 2022Long-term exposure to traffic-related air pollution was linked with higher annual emergency department and outpatient health care costs for older patients, particularly those with cardiovascular disease.
Read More
Too Little Salt May Have an Adverse Impact on People Living With HFpEF
July 18th 2022This new study investigated the impact of overly restrictive salt-intake guidelines on patients living with heart failure with preserved ejection fraction (HFpEF), because despite accounting for half of all HF cases, this patient population is often excluded from studies in the space.
Read More
Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population
The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.
Read More
Potential Link Found Between Heart Failure Prognosis, Changes in RVFAC
July 8th 2022Few data exist on how right ventricular fractional area change (RVFAC) may contribute to outcomes among patients hospitalized for heart failure, so that potential relationship was investigated in this new study from Japan.
Read More
Exercise Capacity in HFpEF Not Impaired by Reduced Diastolic Filling Time
July 2nd 2022Using chronotropic response as a reference, study authors from Japan investigated the potential influence of exercise-induced heart rate on cardiac output reserve and exercise capacity among a cohort of patients with heart failure with preserved ejection fraction (HFpEF).
Read More
Gout Flare Likely Increases Hospital LOS in Heart Failure
June 25th 2022Using the Nationwide Inpatient Database for trends studied between 1993 and 2011, investigators from Columbia University Irving Medical Center evaluated hospitalization outcomes among patients with heart failure and comorbid gout.
Read More
Patients With HFrEF May Benefit From Alternate Method of Sac/Val Dose Titration
June 22nd 2022In this study, Italian investigators evaluated how sacubitril/valsartan (Sac/Val) dose titration among older patients with heart failure with reduced ejection fraction (HFrEF) might affect reverse cardiac remodeling and if the success of up-titration can be predicted.
Read More
Sacubitril/Valsartan Safe, Effective Among CHF Patients on Maintenance Hemodialysis
June 18th 2022Outcomes in this new study, conducted among patients with chronic heart failure (CHF) on maintenance dialysis and receiving sacubitril/valsartan, were evaluated as they pertained to heart function and blood pressure.
Read More